First-line pembrolizumab, trastuzumab, and chemotherapy in advanced HER2-positive gastric cancer with sequential genomic profiling
Hyun Cheol Chung(Yonsei University Health System), Chung Mo Nam(Yonsei University)
Cited by 0
Related Papers
A single arm phase Ib/II trial of first-line pembrolizumab, trastuzumab and chemotherapy for advanced HER2-positive gastric cancer
|Nature Communications|2022|53
<i>PINCH‐2</i> presents functional copy number variation and suppresses migration of colon cancer cells by paracrine activity
|International Journal of Cancer|2014|14